Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,706,980
-$218,648,083 QoQ
Shares Held
119,378
-96.7% QoQ
Ownership
0.204%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. ACLX ranks #140 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in ACLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,706,980 | 119,378 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $232,355,063 | 3,563,728 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $473,004,123 | 5,761,317 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $393,266,140 | 5,972,151 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $413,521,341 | 6,303,679 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $610,194,182 | 7,956,633 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $541,084,087 | 6,479,273 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $358,035,961 | 6,487,334 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $375,187,125 | 5,394,495 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $243,043,879 | 4,379,169 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $162,800,189 | 4,537,352 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $148,329,356 | 4,690,998 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $82,666,002 | 2,683,090 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $40,075,726 | 1,293,600 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,803,298 | 788,668 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $11,276,821 | 623,718 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $182 | 13 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||